GALECTIN THERAPEUTICS INC ($GALT)
Filing Information
| Accession Number | 0001133416-26-000063 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 16, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
48,750
Total Value
$132,684.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jul 14, 2026 | Exercise/Conversion | 16,250 | $3.04 | $49,400.00 | 16,250 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 14, 2026 | Sale | 16,250 | $5.13 | $83,284.50 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock option (right to buy) | Derivative | Jul 14, 2026 | Exercise/Conversion | 16,250 | $0.00 | $0.00 | 48,750 | Direct | โ | View Details |